PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
Dec 23, 2021 · Iona Everson from PMGroup spoke to John Forni, Country Medical Director at Sanofi UK & Ireland, about the escalating challenges of treating chronic obstructive pulmonary disease (COPD) in the UK and how the government, NHS and industry can work together to …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
December 6, 2024 | Genesis Research Group| To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business approaches, Genesis Research Group employed their RPR stakeholder engagement platform …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
Susanne Bobadilla from VML Health, joined by a team of 15 medical, digital strategists and client engagement experts from across the company, looks at the top trends coming out of ESMO 2024 and what they mean for the future of cancer care
PME - Home
How AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
PME - Articles - Pharmaceutical Market Europe
Dec 15, 2024 · Discover the latest articles published by PME. Pharmaceutical industry news, articles, jobs, reports, advice and services!
AbbVie and Neomorph enter molecular glue degrader partnership …
1 day ago · AbbVie has partnered with Neomorph to develop new molecular glue degraders (MGDs) for multiple targets across oncology and immunology, with the deal worth $1.64bn. The collaboration and option-to-licence agreement combines AbbVie’s capabilities in oncology and immunology drug development with ...
PharmaRole - pme.pmlive.com
Discover the latest articles published by PME. Pharmaceutical industry news, articles, jobs, reports, advice and services!
Research - PMLiVE
The research could pave the way for the development of new drugs that prevent drug resistance. Read More
AI AND PHARMA MARKETING - RThe AI tipping point in pharma …
1. Data privacy and compliance AI relies on data, but the risks are high in pharma, where sensitive patient and product information is at stake. Mishandling data can lead to legal violations, reputational damage and erosion of public trust. Existing regulations such as GDPR require organisations to implement data protection by design.
PME - PMLiVE
Pharmaceutical Market Europe – October 2024. Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024